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Optogenetics provides new ways to activate gene transcription; how-
ever, no attempts have been made as yet to modulate mammalian
transcription factors. We report the light-mediated regulation of
the repressor element 1 (RE1)-silencing transcription factor (REST), a
master regulator of neural genes. To tune REST activity, we selected
two protein domains that impair REST-DNA binding or recruitment of
the cofactor mSin3a. Computational modeling guided the fusion
of the inhibitory domains to the light-sensitive Avena sativa light–
oxygen–voltage-sensing (LOV) 2-phototrophin 1 (AsLOV2). By express-
ing AsLOV2 chimeras in Neuro2a cells, we achieved light-dependent
modulation of REST target genes that was associated with an im-
proved neural differentiation. In primary neurons, light-mediated REST
inhibition increased Na+-channel 1.2 and brain-derived neurotrophic
factor transcription and boosted Na+ currents and neuronal firing.
This optogenetic approach allows the coordinated expression of a
cluster of genes impinging on neuronal activity, providing a tool for
studying neuronal physiology and correcting gene expression
changes taking place in brain diseases.
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The development and maturation of the nervous system rely onthe temporally and spatially precise modulation of gene ex-
pression, coordinated by transcriptional enhancers and repressors
that bind specific sequences on gene promoters (1, 2). In this context,
the key role of the repressor element 1 (RE1)-silencing transcription
factor/neural restrictive silencer factor (REST/NRSF, henceforth
referred to as REST) has been extensively reported (3, 4). REST
binds to gene promoters containing the RE1 consensus site and
mediates cell-specific gene repression (5) by recruiting the core-
pressors mSin3a (6) and CoREST (7) at its N- and C-terminal
domains, respectively. Corepressors, in turn, recruit multiple chro-
matin remodeling factors that ultimately repress gene transcription
by densely packing the genomic material. REST levels decrease
during brain development and are relatively low in mature neurons
(8); however, increased REST expression has been reported in a
large array of brain pathologies. In this regard, whether the increase
of REST is protective or deleterious for neural cells is still debated.
A transient increase in REST expression was associated with ho-
meostatic plasticity in vitro, resulting in the repression of Na+
channel 1.2 (Nav1.2) during sustained network hyperexcitation (9).
Moreover, REST is induced by nonautonomousWnt signaling in the
aging brain, protecting neurons from oxidative stress and amyloid
β-induced toxicity (10). On the other hand, increased REST levels
have been associated with the onset of several brain diseases such as
Huntington disease (HD) (11), epilepsy (12), stroke (13), and tu-
mors of neural origin (14, 15). To interfere with REST dysregulation
in neuronal pathologies, various molecular strategies have been
developed with the purpose of restoring the correct levels of ex-
pression of REST target genes (16–18). Such approaches, however,
suffer from a number of limitations, including their transient activity
or the possibility to generate important side effects when used in
long-term applications.
Optogenetics has the ability to exert an on-demand multimodal
control of several cellular processes with appropriate time scales
(19). Recently, an array of light-gated protein modules has provided
the possibility to dissect the function of cellular networks, including
signal transduction (20), translation (21), and transcription processes
(22). Thus, to effectively and dynamically modulate REST activity,
we engineered recombinant light-sensitive proteins able to modulate
REST action, by using interfering domains fused to the photosen-
sitive light–oxygen–voltage-sensing (LOV) 2 domain of Avena sativa
phototrophin 1 (AsLOV2). AsLOV2 comprises an inner flavin-
binding domain and a C-terminal α-helix (Jα) folded in the dark.
On blue light (450–470 nm) stimulation, photon absorption leads
to major conformational changes that result in the unwinding of the
Jα helix and exposure of the C-terminal fused domain (23, 24).
In this work, we demonstrate the activity of two photo-switchable
chimeras composed of AsLOV2 fused to the minimal REST-
interacting sequence of the corepressor mSin3a (25) (AsLOV2-
PAH1) or to the active domain of the REST inhibitor REST-
interacting LIM domain protein (RILP) (26) (AsLOV2-RILP
N313). The former chimera interferes with the recruitment of en-
dogenous mSin3a by direct competition for its binding site with
REST, whereas the latter directly competes with REST-DNA
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binding by binding the Zn-finger domains of the repressor factor.
Both chimeras specifically inhibit REST activity on illumination,
causing an increase in the transcription of REST target genes
and enhanced firing activity in primary neurons. These probes
potentially provide a way to finely tune the transcription of the
large array of REST-controlled neuronal genes, possibly coun-
teracting the long-term changes in gene expression taking place
in brain diseases.
Results
Strategies to Inhibit REST Activity. To modulate REST activity, we
planned to engineer chimeric proteins formed by the light-sensitive
AsLOV2 driving the effects of a REST-interfering domain.
According to our model, AsLOV2 would sterically block the effector
domain fused to its C terminus in the dark, whereas the unfolding of
the Jα-helix upon illumination would cause the reversible exposure
of the effector sequence. Such domains would bind REST, thus
preventing the assembly of the inhibitory complex and consequently
increasing the transcription of REST-target genes (Fig. 1A). To se-
lect REST-interfering molecules, we focused on domains able to
alter two key events in REST activity, namely the recruitment of the
cofactor mSin3a and the REST-RE1 site interaction. To impair
mSin3a recruitment, we used the N-terminal portion of mSin3a
(mSin3a-N205), which was identified as the minimal REST binding
region of mSin3a (6) (Fig. 1B). To interfere with RE1 recognition,
we chose REST-interacting LIM domain protein (RILP), an endog-
enous REST interactor that, by binding to the Zn-finger domains of
the repressor, displaces it from the target chromatin (26, 27). We
used the first N-terminal portion of RILP (RILP-N313), which
contains the minimal REST binding domain (26) (Fig. 1B).
If these domains inhibit the binding of REST, their expression will
result in an increased transcription of REST-target genes. To verify
this hypothesis, we performed gene reporter assays using a construct
in which luciferase expression was driven by the SV40 promoter
fused to a single RE1 cis-site. Both RILP-N313 and mSin3a-N205
were able to decrease REST-mediated inhibition of the SV40 pro-
moter, increasing luciferase transcription, whereas the same peptides
tested on a non–RE1-containing reporter were totally ineffective
(Fig. 1C and Fig. S1A). We then tested the effect of the domains
on nuclear chromatin, by analyzing their ability to modulate the
Fig. 1. Strategies for REST inhibition. (A) Schematic cartoon of the inhibition strategy. mSin3a (Upper) or RILP (Lower) interfering domains are directly fused to
AsLOV2. In the dark, AsLOV2 is in a closed conformation, masking the REST-binding sites. On blue light illumination (470 nm), AsLOV2 unfolds thus freeing the
C-terminal domains to interact with REST, displacing the endogenous mSin3a or the entire REST complex from target DNA. This would result in the increased
transcription of REST-target genes. (B) Schematic representation of REST, mSin3a, and RILP protein sequences. The interacting portions between REST and mSin3a/
RILP are highlighted. PAH1, paired amphipathic helix 1; PET, Prickle Espinas Testin; LIM, Lin11, Isl-1, andMec-3. (C) HeLa cells were transfected with a reporter vector
in which the expression of the luciferase gene is modulated by the SV40 promoter fused to a RE1 cis-site (pGL3-RE1/SV40), in the absence (white bars) or presence
(gray bars) of expression plasmids encoding for mSin3a N205 (N205), RILP N313 (RILPN), or shRNA against REST (sh), as indicated. Control samples (CTRL) were
cotransfected with the empty vector corresponding to the effector plasmids. Luciferase activity was measured 48 h after transfection. Data were first normalized to
the activity of the cotransfected TK-Renilla reporter vector and subsequently to the activity of the reporter gene alone, set to 1 (*P < 0.05; **P < 0.01; one-way
ANOVA followed by the Tukey’s multiple comparison test vs. control; n = 3 independent experiments). Luc/Ren, Luciferase/Renilla ratio. (D) SYN1 and REST mRNA
levels were quantified by qRT-PCR in N2a cells 48 h after the transfection of expression plasmids encoding for mSin3a N205, RILP N313, or shRNA against REST, as
indicated. RPS9, GAPDH, and HPRT1were used as control housekeeping genes. (*P < 0.05 vs. control; one-way ANOVA followed by the Tukey’s multiple comparison
test vs. control; n = 3 independent experiments). (E) Heat map of various RE1-containing and noncontaining genes whose transcription was analyzed by the
NanoString nCounter gene expression system in undifferentiated N2a cells 48 h after the transfection of expression plasmids encoding for mSin3a N205, RILP N313,
shRNA against REST or an empty vector (CTRL). Values were normalized against five housekeeping genes (PPIA; Pgk1; Hdac3; GAPDH; and HPRT) and then reported
as ratio of the control samples. The color represents the expression level of each gene (red for high expression, green for low expression). The analysis was per-
formed using the nSolver Analysis Software 2.5. Primer sequences and numerical values are reported in Tables S1 and S2.
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expression of the neuron-specific SYN1 gene, a well-known REST
target (28), in Neuro2a (N2a) neuroblastoma cells. Indeed, a com-
parable increase in SYN1 gene transcription was apparent when cells
were transfected with either mSin3a-N205 or RILP-N313 or silenced
for REST with shRNAs (Fig. 1D). Interestingly, no change in REST
mRNA levels was revealed under the same experimental conditions,
confirming that expression of either mSin3a-N205 or RILP-N313 did
not affect REST expression, but only REST activity on target genes
(Fig. 1D). A more comprehensive analysis of several REST-target
(n = 21) and nontarget (n = 11) genes was performed using the
NanoString nCounter gene expression system, a technology able to
capture and count individual mRNA transcripts (29). An increase in
mRNA of REST-target genes, comparable to the effect of REST
silencing, was observed in N2a expressing either mSin3A N205 or
RILP N313, whereas no effect was detected on non–REST-target
genes abundance (Fig. 1E and Tables S1 and S2). All together, these
data confirm that the mSin3a-N205 and RILP-N313 interfering
domains effectively decrease REST activity both on exogenous
promoters and on endogenous REST-target genes.
Structural Predictions and Optimization of the AsLOV2-Based Competitor
of the mSin3a/REST Complex. To obtain the optogenetic control of
mSin3a-N205 activity, we directly fused the C terminus of the com-
plete AsLOV2 sequence to the N terminus of the interfering peptide
(AsLOV2-N205). To test whether AsLOV2-N205 activity was con-
formation dependent, we cotransfected N2a cells with the RE1-SV40
reporter and the AsLOV2-N205 chimera containing two light-
insensitive mutated forms of the LOV2 domain: (i) the C450Amutant
mimicking the closed “dark” state (30) and (ii) the I539E mutant
maintaining the unfolded “lit” state by a constitutive destabilization
of the Jα helix (31). Although abundantly expressed, the constitu-
tively open AsLOV2-N205 construct was not able to interfere with
REST (Fig. S2), likely due to a persistent steric blockade by AsLOV2
despite the Jα-helix unfolding. We thus restricted the N205 sequence
to its minimal REST-interacting portion, i.e., the paired amphipathic
helix 1 (PAH1) domain of mSin3a, whose interaction with the N
terminus of REST was previously characterized (25, 32, 33) (Fig. 2A).
The PAH1 structure comprises a bundle of four parallel
α-helices, with the REST-interacting residues situated at one side of the
bundle, close to the N terminus (Fig. 2A). Thus, we anticipated that
by fusing the AsLOV2 C-terminal helix to the N terminus of
PAH1, the REST binding region would be occluded in the dark
state, whereas the light-evoked unwinding of the Jα-helix would
bring the domains apart and make the binding site accessible to
REST. To test this hypothesis and obtain information on the full
protein structure and conformations at atomic resolution, we built
a computational model of the chimera, starting from the previously
determined all-atom structures of the AsLOV2 (in the dark state)
and PAH1 domains (33, 34). First, using the RosettaDock program
(35), we searched the optimal relative orientation of the two do-
mains in an associated complex, starting from arbitrary positions
characterized by a small distance between the AsLOV2 C terminus
and the PAH1 N terminus. Among the best scoring conformations,
we picked the one that minimized the exposure of the REST
binding domain in PAH1. A single protein chain was then created
by connecting the two termini (Fig. 2A). This structure was then
subjected to molecular dynamics (MD) simulations in solution to
assess its stability and investigate its possible conformations. The
two domains maintained their functional folded patterns (Fig. 2B);
however, we observed a high degree of flexibility in the linker re-
gion connecting the AsLOV2-Jα helix to the effector PAH1 that
might induce exposure of the PAH1-REST binding region even in
the dark. To avoid this, we designed a chimera with a truncated
form of the PAH1 domain in which three N-terminal residues were
deleted from the linker and subjected it to MD simulations. Results
showed that the conformation of the truncated chimera is more
stable than the full length, with no exposure of the PAH1-REST
binding surface in the dark state (Fig. S3). In conclusion, the
Fig. 2. Building of the AsLOV2-PAH1 chimera. (A) Model of the AsLOV2-PAH1
chimera resulting from RosettaDock (35) and built using the LOV2 domain of
A. sativa phototropin 1 (PDB ID code 2V1A) and the PAH1 domain ofmSin3a (PDB ID
code 2CZY). The backbone of AsLOV2 and PAH1 domains is represented as gray
ribbons, whereas the LOV2 chromophore and the residues C450, I532, and I539
are represented as ball-and-stick. The linker amino acids are highlighted in red.
(B) Conformational heterogeneity of the full chimera and its two domains along the
MD simulation, calculated as RMSD from the starting structure. Large RMSD
values for the full chimera correspond to highly distorted conformations gener-
ated because of the linker. Snapshots of conformations at different simulation
times are also shown, with the molecular surface represented as transparent
spheres. (C, Upper) Amino acid sequences of AsLOV2-PAH1 constructs, limited to
the linker region. (C, Lower) N2a cells were transfected with a control plasmid
(CTRL) or effector vectors encoding for AsLOV2 alone or AsLOV2-PAH1a, -b, or -c,
as indicated. The expression of the constructs in total cellular lysates was analyzed
by Western blot by using anti-histidine tag antibodies. Specific immunoreactive
bands are indicated with asterisks. (D) Confocal images of N2a cells cotransfected
with GFP-REST and either AsLOV2 alone or AsLOV2-PAH1a, -b, or -c, as indicated.
N2a cells were processed for indirect immunofluorescence using anti-histidine tag
antibodies (red) to detect AsLOV2 constructs or anti-EGFP (green) to detect GFP-
REST. The overlay images (merge) reveal colocalization of REST and the AsLOV2-
PAH1 constructs in the nuclear compartment. (Scale bar, 10 μm.) (E and F) HeLa
cells were transfected with the pGL3-RE1/SV40 reporter vector in the absence
(white bars) or presence (gray bars) of expression plasmids encoding for closed (C)
or open (O) AsLOV2-PAH1a, AsLOV2-PAH1b, AsLOV2-PAH1c (E) or expression
plasmids encoding for the closed double mutant (C450A-I532A) or open AsLOV2-
PAH1b (F). Control samples were cotransfected with the empty vector corre-
sponding to the effector plasmids. Luciferase activity was measured 48 h after
transfection. Data were first normalized to the activity of the cotransfected TK-
Renilla reporter vector and subsequently to the activity of the reporter gene
alone, set to 1. (*P < 0.05; **P < 0.01 ***P < 0.001; one-way ANOVA followed by
the Tukey’s multiple comparison test vs. control or the indicated group; n = 3
independent experiments). Luc/Ren, luciferase/Renilla ratio. (G) Undifferentiated
N2a cells were transfected with plasmids encoding for the closed double mutant
(C450A-I532A) or open variants of the LOV2-PAH1b chimera, as indicated. The
endogenous mRNA levels of SYN1, NAV1.2, and BDNF genes were quantified via
qRT-PCR.GAPDH andHPRT1were used as control housekeeping genes (*P < 0.05;
**P < 0.01; one-way ANOVA followed by the Tukey’s multiple comparison test vs.
control or the indicated group; n = 3 independent experiments). (H) Sholl analysis
of N2a cells transfected with expression plasmids encoding for the closed (C) or
open (O) mutants of AsLOV2-PAH1b and differentiated with Retinoic Acid
(*P < 0.05; **P < 0.01; Student t test; n = 3 independent experiments). Repre-
sentative cells are shown in the Insets. (Scale bar, 20 μm.) CTRL, control; LOV,
AsLOV2; L-PAH1, AsLOV2-PAH1; L-PAH1b C*, AsLOV2-PAH1b (C450A-I532A).
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computational analysis suggests a role of the linker length in the
efficiency of the construct.
Building on these results, we engineered three chimeras with
various linker lengths, obtained by progressively shortening the
N terminus of the PAH1 domain (AsLOV2-PAH1a, -b, and -c;
Fig. 2C, Upper). All of the constructs were abundantly expressed
in N2a cells (Fig. 2C, Lower) in which they colocalized with REST in
the nucleus, whereas AsLOV2 alone was strictly cytosolic (Fig. 2D).
Remarkably, the chimeras were specifically targeted to the nucleus,
i.e., to the appropriate cellular compartment to influence REST ac-
tivity on chromatin, even in the absence of nuclear localization se-
quences. When tested in a gene reporter assay, the constitutively
open PAH1a and PAH1b chimeras significantly inhibited REST
activity on target RE1 elements, whereas the corresponding dark
chimeras or the same probes tested on a RE1-null reporter were
virtually ineffective (Fig. 2E and Fig. S1B). On the other hand, the
PAH1c chimera, containing the shortest linker, inhibited REST ac-
tivity also in the constitutively closed form, suggesting that PAH1
escaped the LOV2 steric inhibition (Fig. 2E). We chose the
AsLOV2-PAH1b construct for all subsequent experiments, as it was
the one showing the best effect in the open conformation. To further
improve the stability of the chimera in the dark, we introduced the
I532A point mutation in the AsLOV2 sequence, known to increase
Jα-helix stability (36). The introduction of the second mutation
completely abolished the residual activity of the dark construct on
the exogenously expressed RE1-SV40 promoter (Fig. 2F). Similarly,
when the AsLOV2-PAH1b constructs were expressed in N2a cells,
the transcription of the endogenous SYN1, NAV1.2, and BDNF
genes, which are well-known REST targets (9, 28), was significantly
up-regulated only in cells containing the open chimera (Fig. 2G). On
the contrary, the analysis of four additional genes not containing
RE1 sites, namely APP, DSCAM, GAP43, and Rcan1, did not detect
any difference (Fig. S4).
To study whether these transcriptional changes were accom-
panied by changes in the neuronal differentiation of N2a cells,
we measured neurite length and arborization after transfection
with the open and closed forms of AsLOV2-PAH1b. We pre-
viously found that differentiation of N2a cells induced by retinoic
acid (RA) treatment is associated with loss of endogenous REST
activity and increased expression of its target genes (28). Indeed,
we found that neurite outgrowth was enhanced in differentiating
N2a cells transfected with the open form of the AsLOV2-PAH1b
with respect to the cells expressing the closed form of the chi-
mera (Fig. 2H). Taken together, the above results indicate that
the optimized chimeric protein AsLOV2-PAH1b effectively in-
terferes with the formation of the REST/mSin3a complex in a
conformation-dependent manner.
Expression and Validation of the AsLOV2-Based Inhibitor of REST-DNA
Binding. To achieve the light-driven modulation of REST-DNA
binding, we used the REST binding domain of RILP. Because the
atomic structure of the RILP protein has not been resolved, it was
not possible to obtain a detailed structural model. Thus, we fused
the C terminus of AsLOV2 in frame with the N terminus of the
previously described RILP N313 domain, obtaining AsLOV2-RILP
N313. The fusion protein was expressed in mammalian cells and
colocalized with REST in the nuclear compartment, similar to what
observed with the AsLOV2-PAH1 probe (Fig. 3A). To verify the
ability of AsLOV2-RILP N313 to inhibit the binding of REST to
specific DNA targets, we performed EMSAs on nuclear extracts
from N2a cells, using a canonical RE1 sequence as probe, and
chimeras containing either the C450A (dark, closed) (30) or the
I539E (lit, open) (31) AsLOV2 mutant (Fig. 3B). In agreement
with the results obtained with the exogenous RE1-SV40 promoter
(Fig. 1C), REST-RE1 binding was reduced on transfection of both
full-length RILP and RILP N313, demonstrating that the latter was
as effective as the full-length protein in inhibiting the REST-DNA
interaction. Interestingly, the intensity of the REST-RE1 specific
band was not affected in cells transfected with the closed AsLOV2-
RILP N313, whereas it was markedly reduced on expression of the
open AsLOV2-RILP N313 chimera (Fig. 3B).
Fig. 3. Engineering of AsLOV2-RILP N313. (A, Left) N2a cells were transfected
with control (CTRL) or effector vectors encoding for AsLOV2-RILP N313 as in-
dicated. The expression of the constructs in total cellular lysates was analyzed by
Western blot by using an anti-histidine tag antibody. The specific immunore-
active band is indicated with an asterisk. (A, Right) Confocal images of N2a cells
cotransfected with GFP-REST and either AsLOV2 alone or AsLOV2-RILP N313, as
indicated. N2a cells were processed using anti-histidine tag antibody (red) to
detect AsLOV2 constructs or anti-EGFP (green) to detect GFP-REST. The overlay
images (merge) reveal colocalization of REST and the AsLOV2-RILP N313 con-
struct in the nuclear compartment. (Scale bar, 10 μm.) (B, Left) gel shift assays of
biotinylated RE1. The probe was incubated with nuclear extracts from un-
differentiated N2a cells that had been previously transfected with the indicated
constructs. RE1-containing bands were revealed by HRP-streptavidin followed
by chemiluminescence. The REST-specific band is indicated with an arrow.
(B, Right) quantification of the REST/RE1 complex is provided, data are expressed as
fold change with respect to the CTRL sample, set to 1 (*P < 0.05; one-way
ANOVA followed by the Tukey’s multiple comparison test vs. control or the
indicated group; n = 4 independent experiments). (C) HeLa cells were trans-
fected with the pGL3-RE1/SV40 reporter vector in the absence (white bars)
or presence (gray bars) of expression plasmids encoding for the closed (C) or
open (O) mutants of AsLOV2-RILP N313, as indicated. Control samples were
cotransfected with the empty vector corresponding to the effector plasmids.
Luciferase activity was measured 48 h after transfection. Data were first nor-
malized to the activity of the cotransfected TK-Renilla reporter vector and
subsequently to the activity of the reporter gene alone, set to 1. (*P < 0.05;
**P < 0.01; one-way ANOVA followed by the Tukey’s multiple comparison test vs.
control or the indicated group; n = 3 independent experiments). Luc/Ren, lu-
ciferase/Renilla ratio. (D) Undifferentiated N2a cells were transfected with
plasmids encoding for the closed or open variants of the LOV2-RILP N313 chi-
mera, as indicated. The endogenous mRNA levels of the SYN1, NAV1.2, and
BDNF genes were quantified via qRT-PCR. GAPDH and HPRT1 were used as
control housekeeping genes (*P < 0.05; **P < 0.01; one-way ANOVA followed
by the Tukey’s multiple comparison test vs. control or the indicated group; n = 3
independent experiments). (E) Sholl analysis of N2a cells transfected with ex-
pression plasmids encoding for the closed (C) or open (O) mutants of AsLOV2-
RILP N313 and differentiated with retinoic acid (*P < 0.05; **P < 0.01; Student t
test; n = 3 independent experiments). Representative cells are shown in the
Insets. (Scale bar, 20 μm.) CTRL, control; L-RILPN, AsLOV2-RILP N313.
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To clarify whether the competition of the REST-RE1 binding
was associated with an inhibition of REST activity, we performed
gene reporter assays using the RE1-SV40 reporter construct and
the AsLOV2-RILP N313 chimeras. Interestingly, the open AsLOV2-
RILP N313 construct was able to increase luciferase transcrip-
tion, whereas no effect was observed when the corresponding
closed construct was used or when both probes were tested on
a RE1-null reporter (Fig. 3C and Fig. S1B). Moreover, the
AsLOV2-RILP N313 open mutant induced a significant increase
in the transcription of the REST target genes SYN1, NAV1.2,
and BDNF, whereas no change was observed by the closed chimera
or on non–RE1-containing genes (Fig. 3D and Fig. S4). We also
investigated whether the open or closed form of AsLOV2-RILP
N313 affected neurite length and arborization in N2a cells.
Similar to what found for AsLOV2-PAH1b, neurite outgrowth
was enhanced in differentiating N2a cells transfected with the
open form of the AsLOV2-RILP N313 with respect to the cells
expressing the closed form of the chimera (Fig. 3E). Altogether,
these data demonstrate that the AsLOV2-RILP N313 chimera
allows a conformation-dependent inhibition of REST activity
through its displacement from target DNA.
AsLOV2-PAH1 and AsLOV2-RILP N313 Inhibit the Formation of the REST
Complex on Target Chromatin. To characterize the molecular mecha-
nisms by which AsLOV2-PAH1b (henceforth AsLOV2-PAH1) and
AsLOV2-RILP N313 affect the activity of the REST complex on
target chromatin, we measured the occupancy of the RE1 locus on
the SYN1 (28) and BDNF (37) promoters by REST and mSin3a
after transfection of either chimera in the open or closed form.
Chromatin from transfected N2a cells was immunoprecipitated with
mSin3a- or REST-specific antibodies, and the respective occupancy
of mSin3a and REST at the SYN1 (Fig. 4A) or BDNF (Fig. 4B)
promoters was evaluated by quantitative PCR (qPCR). Results in-
dicate that the occupancy of mSin3a and REST was significantly
reduced in cells containing the open construct of AsLOV2-PAH1
andAsLOV2-RILP N313, respectively, whereas no significant effects
were observed in the presence of the closed chimeras (Fig. 4). As a
control, we performed ChIP on a non-RE1 promoter, such as the
one of the GAPDH gene. As expected, no differences in promoter
pull-down were observed with both AsLOV2-PAH1 and AsLOV2-
RILP N313 constructs (Fig. S5). Thus, AsLOV2-PAH1 and AsLOV2-
RILP N313 interfere with the formation of the multiprotein REST
complex in a conformation-specific way.
Light-Driven Modulation of REST Activity. To evaluate the activity of
the WT AsLOV2 constructs in response to specific patterns of
illumination, N2a cells were transfected with the light-sensitive
AsLOV2-PAH1 or AsLOV2-RILP N313 vectors. The transcrip-
tion profile of the REST-regulated genes BDNF, SYN1, SNAP25,
and NAV1.2 was measured after blue light illumination using a
custom-made apparatus powered by an Arduino-driven array of
blue LEDs (emission peak: 470 nm; Fig. 5A). Considering that
AsLOV2 is known to return to the closed conformation in a
timescale of tens of seconds (38–40), we tested several light/dark
duty cycles by varying the relative duration of the dark vs. light
period and selected for our experiments the best performing
protocol, which used constant dark/light pulses (with 1-s pulses at
0.5 Hz). In a first series of experiments, we monitored cell via-
bility by varying light intensity, keeping constant the light/dark
duty cycle (Fig. 5B). When N2a cells were exposed to 470-nm
LED illumination of increasing intensity for 48 h, we reported an
optimal viability up to 0.55-mW/cm2 irradiation power, whereas
higher intensities induced a progressively increasing percentage
of cell death. Thus, to minimize phototoxic damage, a light
power of 0.34 mW/cm2 was used in all subsequent experiments.
We then transfected undifferentiated N2a cells with either
AsLOV2-PAH1 or AsLOV2-RILP N313. After 24 h, cells were
transferred to the illumination apparatus and subjected to the
light stimulation protocol. A significant increase in the tran-
scription of the BDNF, BDNFII, SYN1, SNAP25, and NAV1.2
mRNAs was observed on illumination in cells expressing either
chimera. No increase in gene transcription was observed in
parallel samples kept in the dark or in control cells transfected
with AsLOV2 alone and exposed to the same illumination pat-
tern (Fig. 5C). The transcription of non-REST target genes
DSCAM, GAP43, and Rcan1 did not change under all conditions
tested (Fig. S6), confirming that gene up-regulation was specif-
ically driven by light acting on the light-sensitive constructs at the
level of RE1-containing genes. Although the increase in tran-
scription of the tested REST target genes varied in magnitude,
the two chimeras had comparable effects on transcription, in-
dicating a final common pathway of REST inhibition.
Next, we wanted to define the time course of the light-induced
transcriptional changes from the beginning of the light stimula-
tion protocol up to a maximum time of 48 h, using BDNF as a
target gene. We found that, with both AsLOV2 chimeras, BDNF
expression levels significantly increased already after 12 h of il-
lumination, reached a plateau of ∼1.5- to 2-fold increase after
24 h (Fig. 5D, Left), and returned to baseline levels in ∼12 h after
switching off the light (Fig. 5D, Right). To evaluate whether the
Fig. 4. AsLOV2-PAH1 and AsLOV2-RILP N313 impair the formation of the REST
complex on target chromatin. N2a cells were transfected with the indicated
expression vectors and then subjected to chromatin immunoprecipitation of the
SYN1 (A) or BDNF (B) promoter regions using 2 μg anti-mSin3a, anti-REST, or
anti-rabbit IgG antibodies, as indicated. mSin3a or REST binding was normalized
against the input DNA value and subsequently normalized to the binding in the
control (AsLOV2) sample, set to 1 (*P < 0.05; **P < 0.01; one-way ANOVA
followed by the Tukey’s multiple comparison test vs. control or the indicated
group; n = 3 independent experiments). LOV, AsLOV2; L-PAH1, AsLOV2-PAH1;
L-RILPN, AsLOV2-RILP N313.
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observed changes in mRNA levels were followed by a parallel
change in protein levels, BDNF protein was measured in cell
extracts by Western blotting after 48 h of light stimulation. As
expected, a significant increase in BDNF protein was observed
only in N2a cells expressing the active probes and exposed to
light (Fig. 5E). Taken together, these data demonstrate that both
AsLOV2-PAH1 and AsLOV2-RILP N313 effectively act as light-
modulated inhibitors of REST activity on target genes, resulting
in increased levels of transcription and translation.
Transduction of AsLOV2-PAH1 in Primary Neurons Increases Intrinsic
Excitability. We previously reported that REST activity can influ-
ence neuronal firing through the modulation of NAV1.2 gene
transcription (9). To study the effects of the light-driven modula-
tion of REST in primary neurons, we engineered a bidirectional
lentiviral vector expressing AsLOV2-PAH1 and EGFP. Once
transduced into primary neurons, the probe showed a clear en-
richment in the nuclear compartment, similar to what observed in
transfected N2a cells (Fig. 6A, see also Figs. 2D and 3A). Primary
cortical neurons were infected at 7 d in vitro (DIV) and then
subjected to 470-nm light stimulation at 12 DIV for 24 h. Starting
from the illumination parameters used for N2a cells, we optimized
our protocol for primary neurons, by changing both the illumina-
tion intensity and the duty cycle. We found that the optimal con-
ditions for primary neurons, which maximized cell viability while
inducing appreciable changes in gene transcription, were
0.34mW/cm2; 250-ms pulses; 0.25Hz. The analysis of gene transcription
reported a significant increase in both NAV1.2 and BDNF mRNAs
in AsLOV2-PAH1 infected neurons exposed to light compared
with the same neurons kept in the dark or to neurons infected with
a control vector expressing only EGFP (Fig. 6B), indicating that
the lentiviral probe was effective in inhibiting REST activity in
primary neurons.
Next, we analyzed whether the optogenetic suppression of
REST activity was associated with changes in intrinsic neural
excitability. The resting potential of transduced neurons was not
affected by the expression of the chimera and/or the light stim-
ulation protocol (Fig. 6C). Then, transduced neurons, held at a
membrane potential of –70 mV in whole-cell current-clamp
mode were subjected to current injection of 500-ms duration and
stepwise increasing amplitude. Interestingly, neurons expressing
AsLOV2-PAH1 and subjected to light stimulation displayed a
strongly increased firing frequency compared with the same
transduced neurons kept in the dark or to parallel cultures in-
fected with the control vector (Fig. 6D), in the absence of sig-
nificant changes in the passive membrane properties or in action
potential shape (Table S3). We then analyzed the Na+ current
density to verify whether the increased NAV1.2 transcription was
associated with an increased amount of functional channels ex-
posed on the neuronal membrane. The plot of the current-
voltage relationship in cortical neurons expressing AsLOV2-
PAH1 and subjected to light stimulation revealed that the
changes in NAV1.2 transcription were paralleled by a significant
increase in the maximum Na+ current density with respect to
neurons expressing AsLOV2-PAH1 and kept in the dark or to
control neurons expressing EGFP only (Fig. 6E). Interestingly,
the increase in the firing frequency (Fig. 6D) and in the Na+
current density (Fig. 6E) obtained by optogenetic inhibition of
REST activity with either probe was fully comparable with that
obtained by silencing REST with a lentiviral vector expressing a
REST shRNA (9). These observations demonstrate that the
AsLOV2-PAH1 probe is able to influence REST activity in pri-
mary neurons by inducing light-evoked transcriptional regulation
with functional consequences on neuronal activity.
Fig. 5. Photostimulation of AsLOV2-PAH1 and AsLOV2-RILP N313 constructs. (A) Illustration of the illumination protocol and LED stimulation apparatus.
(Upper) Cells were seeded at day 0 and transfected at day 2. The illumination protocol was started 1 d after transfection, for 48 h. (Lower) Cells are 1.5 cm
above a 470-nm light emitting LED. (B) Effect of light exposure on N2a cells viability. Cells were subjected to 470-nm light illumination (0.5 Hz) at the indicated
intensities, and viability was measured after 48 h of stimulation (*P < 0.05; one-way ANOVA followed by the Tukey’s multiple comparison test vs. control; n =
3 independent experiments). (C) Undifferentiated N2a cells were transfected with the indicated constructs and then subjected to 470-nm light illumination
(0.5 Hz) or kept in the dark, as indicated. After 48 h, the mRNA levels of the indicated genes were quantified via qRT-PCR. GAPDH and HPRT1 were used as
control housekeeping genes (*P < 0.05; **P < 0.01; Student t test; n = 3 independent experiments). (D) Time-course of light-dependent BDNF up-regulation
and postillumination recovery (*P < 0.05; Student t test vs. respective dark condition; n = 3 independent experiments). (E) Western blot analysis of BDNF in
undifferentiated N2a cells transfected with the indicated constructs. A representative experiment is shown on the left, whereas the quantification is shown on
the right (*P < 0.05; Student t test vs. the respective dark conditions; n = 3 independent experiments). LOV, AsLOV2; L-PAH1, AsLOV2-PAH1; L-RILPN, AsLOV2-
RILP N313.
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Discussion
In this work, we describe an optogenetic approach aimed at
modulating gene transcription in a dynamic and reversible way,
by acting on the activity of the master transcriptional repressor
REST. We engineered chimerical proteins based on the blue light
absorbing AsLOV2 domain and exploited the inhibitory potential of
small protein domains belonging to the endogenous REST inter-
actors mSin3a and RILP/PRICKLE1. Following this strategy, we
were able to target two key events in REST physiology: (i) the as-
sembly of the repressor complex on RE1 sites and (ii) REST binding
to DNA. Optogenetic activation of our LOV-based opto-probes
selectively induced transcription of REST target genes in neuro-
blastoma cells and in primary neurons. By applying specific illumi-
nation protocols, we were able to drive and modulate important
physiological processes, such as the neural differentiation of N2a cells
and the firing properties of cortical neurons.
Fig. 6. AsLOV2-PAH1 inhibits REST activity in primary neurons. (A) Confocal images of primary cortical neurons infected with a bidirectional lentiviral vector expressing
either EGFP (CTRL) orAsLOV2-PAH1/EGFP. Neurons were stained using anti-Histidine tag antibodies (red) to detect the AsLOV2 construct, and anti-EGFP (green) antibodies
to detect EGFP. (Scale bar, 10 μm.) (B, Upper) Schematic representation of the time course of the experiment: neuronswere infected at day 7, the illumination protocol was
started 5 d after infection (day 12) for 24 h. (B, Lower) qRT-PCR for NAV1.2 and BDNFmRNA in EGFP (CTRL) or AsLOV2-PAH1–expressing neurons kept under dark (gray
bars) or lit (blue bars) conditions for 24 h. GAPDH and HPRT1 were used as control housekeeping genes (*P < 0.05; one-way ANOVA followed by the Tukey’s multiple
comparison test vs. the respective dark control; n = 3 independent experiments). (C) Resting potential of cortical neurons infected with CTRL and AsLOV2-PAH1 and kept
for 24 h under either dark or lit conditions. No significant differences were observed among the various conditions. (D, Upper) Plot of themean (±SEM) firing frequency vs.
injected current (F/I curve) in cortical neurons infected with either AsLOV2-PAH1 (closed symbols) or EGFP alone (CTRL, open symbols) and subjected to either 24-h light
(blue symbols) or 24-h dark (gray symbols) (AsLOV2-PAH1/dark, n = 22; AsLOV2-PAH1/light, n = 21; EGFP/dark, n = 19; EGFP/light, n = 20; from three independent ex-
periments). Representative current-clamp recordings of spike trains evoked by injection of 225 pA for 500 ms in neurons infected with AsLOV2-PAH1 and kept for 24 h
under dark (black) or lit (blue) conditions are shown on the left. (D, Lower) The same experiment was performed in neurons infected with either a scrambled shRNA or
shRNA against REST (n= 11 for each condition). (E) Mean current–voltage (I/V) relationship expressed as current density in cortical neurons infected with AsLOV2-PAH1,
EGFP alone, scrambled shRNA, or shRNA against REST. Experimental conditions were as described in D (n= 30 for each condition). The stimulation protocol and repre-
sentative INa
+ traces obtained in the cell-attached configuration at various voltages are shown on the Upper Left. Current density was calculated by normalizing the Na+
current amplitude to the cell capacitance and plotted as means (±SEM) vs. the applied voltage. The mean (±SEM) peak Na+ current density evoked at −20 mV in the
indicated groups is shown in the bar plot on the Lower Left. In D and E, *P < 0.05; **P < 0.01; ***P < 0.001; two-way ANOVA followed by the Bonferroni’s multiple
comparison test. LOV, AsLOV2; L-PAH1, AsLOV2-PAH1; L-RILPN, AsLOV2-RILP N313; shREST, shRNA for REST; sc-shRNA, scrambled shRNA.
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Due to its crucial role in several neuropathologies (10, 11, 13, 14,
41, 42), various molecular strategies have been developed to target
REST activity, including decoy oligodeoxynucleotides, interfering
peptides, and stable expression of dominant-negative/constitutively
active forms of REST (14, 16, 17). These approaches have been
applied to a number of pathological models, including HD and
medulloblastoma, encountering various levels of success. How-
ever, all these approaches are burdened by intrinsic limitations
such as the rapid degradation of the probes or the constitutive
and nontunable activation of REST-target genes, which may lead
to unwanted side effects. The optogenetic tools described here
are endowed with several features that circumvent these limita-
tions, such as (i) their effect is reversible and can be finely
modulated by specific illumination protocols; (ii) they can be
used for long-term applications, being genetically encoded; and
(iii) they counteract REST dysregulation without affecting
REST expression.
Recently, various genetically encoded tools have been pro-
posed to remotely control gene activity using light. Such tools
were able to regulate the transcription of individual endogenous
genes, such as the Vivid LOV (43) or the TALE-associated
CRY2-CIB1-VP64 tool (22), or to modulate the activity of ex-
ogenous DNA (44). These mechanisms can effectively target the
transcription of single genes. However, many cellular events are
strictly dependent on the simultaneous and coordinated changes
in the transcription of gene clusters, resulting from an increased
or reduced activity of one or more transcriptional regulators. In
this respect, our strategy is, to our knowledge, the first attempt
to directly modulate an endogenous transcription factor, thus
achieving the coordinated regulation of a cluster of neuron-
specific genes.
The ability to regulate the activity of transcription factors rep-
resents an essential step for a better understanding of the molec-
ular and epigenetic mechanisms that constitute the basis of cell
physiology, and a promising approach in the treatment of pathol-
ogies linked to dysregulation of specific gene clusters. Epigenetic
modifications recently emerged as a crucial event to rapidly adapt
the neuronal transcriptional response to developmental and envi-
ronmental hints (45). In this context, REST plays a central role in
the determination of the neuronal fate (46), as well as in the
modulation of neuronal activity and plasticity (9). The role of REST
in the onset of pathologies is complex, acting under some circum-
stances as an oncogene and under other conditions as a promoter of
insult-induced neuronal death (brain ischemia, HD) (11, 13, 41) or
dysfunction (epilepsy) (42). Thus, a fundamental objective of next
investigations would be to express the REST-modulating probes in
vivo in experimental models of brain pathologies associated with
REST overexpression or hyperactivity. To render the REST opto-
probes useful for long-term experiments in vivo, we are currently
engineering “self-activatable” optogenetic tools coupled to chemi-
luminescent probes that would emit light only on the injection of
specific substrates, thus avoiding the implant of an optical fiber (47).
In conclusion, this work describes a previously unexplored
optogenetic strategy to control the activity of an endogenous
transcription factor, thus achieving the coordinated regulation of a
large gene cluster. This approach allowed us to modulate funda-
mental physiological processes such as the neural differentiation of
neuroblastoma cells and the intrinsic excitability of primary neu-
rons and opens the possibility to devise novel therapeutic strategies
for brain diseases based on the optogenetic control of the neuronal
epigenome.
Materials and Methods
Materials. All biochemical reagents and drugs were from Sigma-Aldrich,
unless otherwise specified. Tissue culture reagents and media were from
Gibco-Invitrogen (Life Technologies) or Sigma-Aldrich. The complete list of
primary and secondary antibodies used throughout the paper is available in
the SI Materials and Methods.
Mammalian Cell Culture and Light Stimulation Experiments. Murine Neuro2a
(N2a) neuroblastoma cells and human HeLa cells were cultured in DMEM
(#11965-092) supplemented with 10% (vol/vol) FBS, glutamine (2 mM), and
antibiotics, in a humidified 5% CO2 atmosphere at 37 °C. For light stimula-
tion experiments, 750,000 cells were plated in 35-mm dishes, and the day
after were transfected with 2.5 μg of the indicated vectors. Twenty-four
hours after transfection, cells were subjected to light stimulation. Stimula-
tion parameters were as follows: 0.34 mW/cm2, 470 nm, and 50% duty cycle
(1-s light pulses) for the indicated time. After the stimulation period, RNA
was extracted. For the control dark points, cells were maintained in the in-
cubator wrapped in aluminum foil, to ensure complete dark conditions.
Sholl Analysis. Undifferentiated N2a cells were transfected with the indicated
constructs and subjected to RA treatment as previously described (28). Cells
were fixed after 2 d and stained for β III tubulin and histidine. Images were
acquired using an upright Leica TCS SP5 AOBS TANDEM confocal microscope
equipped with a 20×/0.50 W UVI objective. At least 20 cells were analyzed
for each condition, from three independent cell culture preparations. Sholl
analysis was performed by using the Sholl plugin of ImageJ (starting radius
10 μm, radius step size 5 μm, ending radius 200 μm).
Protein extraction and Western blotting were performed following
standard biochemical procedures. Details are provided in SI Materials
and Methods.
Oligonucleotides and EMSA. The RE1 cis-site sequence (5′-GTCGGATTCAG-
CACCACGGACAGCGCCCCT-3′) was chemically synthesized (Sigma-Aldrich).
Fragments were end-labeled with biotin using the biotin 3′ end labeling kit
(#89818; Pierce Biotech.). For each gel-shift reaction, a total of 20 nM biotin-
labeled probe was dissolved in binding buffer [100 mMHepes, pH 7.2, 400 mM
KCl, 30 mM MgCl2, 10 mM DTT, 50% (vol/vol) glycerol] with 500 ng nuclear
extracts and 100 ng poly(dI-dC). The reaction mixture was incubated for 25 min
at room temperature and then resolved on a nondenaturing 6% (vol/vol)
polyacrylamide gel. The signal of the biotin-labeled DNA was detected by
using the Light Shift chemiluminescent EMSA kit (#20148; Pierce Biotech.).
ChIP. A total of 10 × 106 N2a cells were incubated 10min in 10mL DMEM + 1%
formaldehyde, and then 1 mL of 1.25 M glycine was added for 5 min. After,
cells were washed twice with cold PBS and collected by centrifugation. The
pellet was suspended in 300 μL swelling buffer [25 mM Hepes, pH 7.8, 1.5 mM
MgCl2, 10 mMKCl, 0.1% octylphenoxypolyethoxyethanol (IGEPAL), 1 mMDTT,
0.5% PMSF, protease inhibitor mixture], incubated 10 min on ice, briefly vor-
texed, and centrifuged 5 min at 2,000 × g at 4 °C. The supernatant was re-
moved, and the nuclear pellet was suspended in 200 μL Nuclei Lysis Buffer
(50 mM Tris·HCl, pH 8.0, 10mM EDTA, 1% SDS, protease inhibitor mixture) and
incubated 10min on ice. DNAwas fragmented by five cycles of sonication using a
Branson Sonifier (Power 1) and centrifuged 15 min at 10,000 × g, at 4 °C. The
formaldehyde-fixed DNA-protein complex (100 μL) was added to 900 μL of
immunoprecipitation dilution buffer (0.01% SDS, 1.1% Triton X-100, 1.2 mM
EDTA, 16.7 mM Tris·HCl, pH 8.0, 167 mM NaCl, 1 mM PMSF, protease in-
hibitor mixture) and incubated with 2 μg specific antibody ChIPAb+ REST,
anti-mSin3A (K-20), or anti-rabbit IgG antibodies (#PP54B; Millipore) for 2 h
at 4 °C. Antibodies were previously bound to protein A beads (Dynabeads
Protein A; Life Technologies) by 2-h incubation at 4 °C on a rotating wheel.
DNA from a 100-μL aliquot from all experimental conditions was de–cross-
linked and extracted as described below, to be used as input. After immu-
noprecipitation, samples were washed three times with 1 mL RIPA buffer
(10 mM Tris·HCl, pH 7.5, 1 mM EDTA, 140 mM NaCl, 0.5 mM EGTA, 1% Triton
X-100, 0.1% SDS, 0.1% Na-deoxycolate) and two times with 1 mL TE buffer
(10 mM Tris·HCl, pH 8.0, 10 mM EDTA). Washed beads were pelleted, and
40 μL of 10% (vol/vol) Chelex-100 (#142-1253; Bio-Rad) was added. After a brief
vortexing, samples were boiled for 10 min and then cooled to room tem-
perature. One microliter Proteinase K (20 mg/mL) was added, and samples
were incubated at 55 °C, 30 min on a thermomixer under constant shaking.
Samples were then boiled 10 min and pelleted. Supernatant, containing de–
cross-linked DNA, was transferred in clean tubes. Five microliters purified
DNA was used for qPCR. The efficiency of ChIP was quantified on a standard
curve prepared using various concentrations (from 100 to 5 ng) of genomic
DNA. The amount of precipitated DNA was determined as relative to 1%
input chromatin as (amount of ChIP DNA/amount of input DNA) × 100. The
complete list of ChIP primers is available in Dataset S1.
Plasmids and Transfections. Details about the plasmids used and relative
cloning strategies are available in SI Materials and Methods. Reporter and
expression vectors were transiently cotransfected into cultured cells using
Lipofectamine 2000 (Life Technologies) following standard transfection
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procedures. Control samples were cotransfected with the empty vector
corresponding to the effector plasmids. pRL-TK-SV40 control plasmid was
used as internal control. Luciferase activity was assayed after 48 h using the
Dual-Luciferase reporter assay system (#E1910; Promega).
AsLOV2 Mutagenesis. To obtain AsLOV2 C450A and I532E mutants, 50 μg WT
pcDNA3.1His/AsLOV2-PAH1 or pcDNA3.1His/AsLOV2-RILP N313 vectors were
PCR amplified using Pfu DNA polymerase (#M7745; Promega). The complete
list of primers is available in Dataset S1. PCR conditions were as follows:
95 °C, 5 min; 95 °C, 30 s; 55 °C, 30 s; 72 °C, 13 min; 30 cycles for pcDNA3.1His/
AsLOV2-PAH1 mutants and 95 °C, 5 min; 95 °C, 30 s; 55 °C, 30 s; 72 °C, 14 min;
30 cycles for pcDNA3.1His/AsLOV2-RILPshort mutants. PCR products were
digested using the DpnI enzyme (Promega) and transformed into DH5α cells.
Positive colonies were verified by DNA sequencing.
RNA Preparation and qRT-PCR. Total cellular RNA was extracted using TRIzol
(Life Technologies), and isolated RNA was subjected to DNase I (Promega)
treatment. cDNAwas synthesized starting from 0.5 μg treated RNA according
to the High-Capacity cDNA Reverse Transcription Kit manual (#4368814;
Applied Biosystems) and used for qRT-PCR. The complete list of qRT-PCR
primers is available in Dataset S1. For the Nanostring analysis of REST target
and nontarget genes, fluorescently labeled probes were designed and syn-
thetized by Nanostring Technologies (Table S1). One hundred nanograms
total RNA per sample, prepared as described above, was processed in the
Center for Genomic Science, Istituto Italiano di Tecnologia, Milano (Italy),
following standard procedures. Data were analyzed by using the nSolver
Analysis Software Version 2.5.
Immunofluorescence and Confocal Microscopy. Cellswere fixedwith 4% (wt/vol)
paraformaldehyde and 20% (wt/vol) sucrose in PBS for 15 min at room tem-
perature and permeabilized with 0.1%. Triton X-100 in PBS for 5 min at room
temperature. Samples were blocked for 30 min in immunofluorescence buffer
[2% (wt/vol) BSA, 10% (vol/vol) goat serum in PBS]. Primary and secondary
antibodieswere diluted in immunofluorescence buffer and incubated for 45min
at room temperature. Coverslips were mounted using ProLong antifade
(#P36931; Life Technologies) and imaged by confocal microscopy. Confocal
fluorescent images were obtained using a Leica SP5 confocal scan with a 40×
objective and analyzed with the Leica LAS AF software.
Photostimulation Hardware. In vitro light stimulation experiments were
performed using a custom built LED photostimulation device, which was
fabricated with a precision-machined aluminum mounting plate and a 5-W
high efficiency Blue LED array, with peak emission at 470 nm. LED intensity
was regulated by a separate, 12 channels low-noise, linear power driver; on-
off operation (and duty cycle) was modulated by an ARDUINO 2000 micro-
controller (the system can accept every TTL or digital positive signal to enable
channels output or can be used in stand-alone mode). Radiation output was
measured from a distance of 1.5 cm above the array using a Thorlabs PM100
power meter and an S121b circular sensor probe. The complete Arduino code
is available in Dataset S1.
Electrophysiological Recordings. Primary cortical cultures were prepared from
mouse C57BL/6J (E17–E18) embryos as previously described (48). All experi-
ments were carried out in accordance with the guidelines established by the
European Communities Council (Directive 2010/63/EU of 22 September 2010)
and were approved by the Italian Ministry of Health. Lentivirus production
and infection were performed following standard procedures (details are
provided in SI Materials and Methods). Neurons were infected with lentiviral
vectors encoding GFP, AsLOV2-PAH1b/GFP, scrambled/mCherry or REST
shRNA/mCherry (9) and subjected to 24-h light stimulation or kept in the
dark. One day after the end of the stimulation protocol, excitability and Na+
current density were studied by patch-clamp recordings in current-clamp
and voltage-clamp configurations. All experiments were performed on
transduced neurons identified by green or red fluorescence using a Multi-
clamp 700B amplifier (Axon Instruments, Molecular Devices) and an upright
bx51WI microscope (Olympus) equipped with Nomarski optics. Current-
clamp recordings were performed at a holding potential of −70 mV, and
action potential firing was induced by injecting current steps of 25 pA
lasting 500 ms. Sodium currents were obtained by stepping from a holding
potential of −90 to −70 to +50 mV with 10-mV steps. Details about
recordings and experimental conditions are provided in SI Materials
and Methods.
Computational Methods. An all-atom model of the chimera was built starting
from the available high-resolution structures of the AsLOV2 (dark state) and
PAH1 domains [Protein Data Bank (PDB) ID codes 2V1A and 2RMR] (33, 34).
An optimal relative orientation for the two domains was determined using
the RosettaDock software (35). The program generates several conforma-
tions of the encounter complex using random orientations and selects those
with low energy values. We used as starting pose a conformation where the
AsLOV2 C terminus was close to the N terminus of PAH1. Among the low
energy conformations obtained, we selected those minimizing the exposed
PAH1 binding domain. A single protein chain was then created by connecting
the two termini with a chemical bond. The chimeric system, amounting to about
90.000 atoms, was then solvated in water box, neutralized with counter ions,
and studied by MD simulations. Details about the simulation input parameters
and methods are provided in SI Materials and Methods.
Statistical Analysis. Results are expressed as means ± SEM throughout. Data
were analyzed by either the unpaired Student t test or one-way ANOVA
followed by multiple comparison tests, as indicated in the text.
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